The experiment assessed the cardiorespiratory and hemogasometric profiles in female cats under sevoflurane resulting from the administration of tramadol. Twenty clinically healthy adult female cats separated equally into two groups: control group (CG) and tramadol group (TG) were sedated with intramuscular acepromazine (0.05 mg/kg), followed by anesthetic induction intravenous propofol (5mg/kg). After endotracheal intubation, animals were maintained on sevoflurane in oxygen administered using a non-rebreathing (Baraka) circuit. The oxygen flow-rate was maintained at 2 L per minute. Fifteen minutes after induction, either 0.05 ml/kg 0.9% saline solution or 2mg/kg tramadol were administered, both intramuscularly, to the animals in CG and TG, respectively. The period of time immediately previous to these administrations was considered as moment zero (T0). The variables were again measured 15 minutes later (T15) and subsequently in 15 minute intervals for a total of sixty minutes (T30, T45 and T60). The results were statistically evaluated through variance analysis of repeated measures (ANOVA) followed by a Tukey test or Student t-test with the nullity hypothesis rejection level set to p<0.05. The use of tramadol reduced cardiac frequency (CF), systolic arterial pressure (SAP), diastolic arterial pressure (DAP) and mean arterial pressure (MAP). There was a reduction of the respiratory frequency (RF) and an elevation of the PaCO 2 . The body temperature (ºC) lowered in both groups throughout the experiment. The results allow us to conclude that tramadol in cats anesthetized with sevoflurane does not undergo significant cardiorespiratory and blood-gas changes, although there are significant differences in some parameters between groups, all results remained within feline standard physiological values.
INTRODUCTION
Sevoflurane is a non-flammable isopropylic fluorited volatile anesthetic that has been routinely used since 1990 (RESENDE et al., 2000; MASSONE, 2008) . This inhalational anesthetic affects the cardiovascular system through reduction of mean arterial pressure, increase of myocardial contractility, without sensitizing the myocardium to the action of epinephrine (NAVARRO et al., 1994) and slight increase of heart rate (BERNARD et al., 1990; BERNARD et al., 1992) . The increase in heart rate is not adequate to maintain proper cardiac output, because the peripheral vascular resistance is decreased. (HIKASA et al., 1997) . When compared to the effects of other volatile anesthetics used in humans, sevoflurane seems to be one of those that offer better cardiovascular stability (EBERT, HARKIN, MUZI, 1995) Sevoflurane does not promote significant respiratory rate changes when compared to isoflurane (HIKASA et al., 1996) . Moreover, in cats, the degree of hypercapnia and acidosis produced by sevoflurane does not differ from that caused by isoflurane, and is less than that when compared with induction by halothane or enflurane (HIKASA et al., 1997) . In cats, the degrees of hypercapnia and acidosis are lower when sevoflurane is used (PYPENDOP, ILKIW, 2004) Sevoflurane anesthesia in female cats spontaneously ventilated can induce respiratory acidosis and increase in carbon dioxide at the end of expiration (SOUZA et al., 2005) . Given that sevoflurane has only recently been introduced to feline anesthesia, there are not many studies carried out in cats (MOUTINHO, 2010) .
Tramadol is an analgesic with a dual mechanism of action. It both binds to the ߤL opioid receptor as agonist (GUEDES et al., 2005; KUKANICH, PAPICH, 2005) and inhibits the monoaminergic pathway which is responsible for noradrenaline (NA) and serotonin (5HT) reuptake (KUBOTA et al., 2008; MCMILLAN et al., 2008) . For this reason, tramadol is considered an "atypical opioid" and is only partially inhibited by naloxone, an opioid antagonist (FANTONI, 2010) . Preemptive M. S. et al. administration of tramadol has been performed to significantly reduce the amount of inhalant anesthetic required for procedures in humans (WORDLICZEK et al., 2002) and dogs (OZKURT, 2002; SEDDIGHI et al., 2009) Several clinical studies have reported the absence of significant respiratory depression using an analgesic dose of tramadol (RADBRUCH, GROND, LEHMANN, 1996) . Other studies, however, have indicate that under some circumstances, tramadol may cause respiratory depression (TEPPEMA et al., 2003) The aim of this study was to assess the cardiopulmonary and acid base effects of tramadol in cats anesthetized by sevoflurane.
MATERIAL AND METHODS
This study was approved by the University of Uberaba's Animal Experimentation Ethics Committee (CEEA). Twenty clinically healthy adult female cats, weighing between 2 and 3 kilograms (2.5 + 0.5 kg) were used. The cats were housed individually in stainless steel cages and fed commercial dry food and water ad libitum. Food was withdrawn 8 to 12 hours and water 2 hours before anesthesia. After fully recovering from anesthesia, animals were returned to their cages and fed as described previously.
Anesthetic procedures
The cats were separated into two groups of ten animals each: Control Group (CG) or Treated Group (TG). Animals received as premedication acepromazine maleate ( Vetnil Ltda) (0.05 mg/kg) intramuscularly. All cats were induced with intravenous propofol (Propovan, Cristália) at 5 mg/kg and were intubated with endotracheal tubes (size range: 3.0-4.0). Anesthesia was maintained with sevoflurane (Sevocris, Cristália) diluted in 100% oxygen at a flow rate of 300 ml/kg/min, through a Baraka (Oxigel) system fed by a universal vaporizer. Fifteen minutes after anesthetic induction, animals were intramuscularly treated with 0.05ml/kg 0.9% saline (Eurofarma) (CG) or 2mg/Kg tramadol (Tramadon; Cristália) (TG).
Cardiopulmonary measurements
The following parameters were measured:
• Heart rate (HR), using the R-R interval, obtained from a computerized electrocardiograph (TEB -ECGPC VET);
• Hemoglobin Oxigen saturation was obtained, as a percentage (%), from an oximeter attached to the animal's tongue (Omni 600 -Omnimed).
• Systolic (SAP), diastolic (DAP) and mean (MAP) arterial pressures were measured from time zero (T0) to time sixty (T60) using an oscillometric pressure monitor (Omni 600 -Omnimed).
• Respiratory rate (RR) and end-tidal carbon dioxide partial pressure (PETCO 2 ), were obtained through the use of a multiparametric monitor (Omni 600 -Omnimed) with the sensor placed between the tracheal tube and the anesthesia circuit;
• Arterial pH (pH), arterial partial pressure of carbon dioxide (PaCO 2 ), arterial partial pressure of oxygen (PaO 2 ), plasma bicarbonate (HCO 3 ), base deficit (BD) and arterial oxygen saturation (SaO 2 ) were measured from arterial blood samples, drawn from the femoral artery, and immediately analyzed by a digital blood gas analyzer (Clinical Analyzer OMINI-CRoche), which is designed to calibrate automatically each time a new cartridge is inserted.
Before the anesthetic induction, the hair was clipped from the right femoral triangle and 1 ml of lidocaine chlorhydrate (Xylestesin, Cristália) was infiltrated over the femoral artery. The femoral artery was then exposed through a skin incision to allow puncture of the artery in order to collect the first blood sample (T0). For the other measurements (T15-T60) the blood samples were collected through the same catheter used for the measurement of the arterial blood pressure. The measurements began right before the tramadol and the saline were administered (T0) and the following blood drawn and data recording took place in 15 minute intervals for 60 minutes (T15, T30, T45 e T60) during volatile anesthesia.
Statistical analyses
Data were analyzed by one-way analysis of variance for repeated measurements to compare time-related variables within each anesthetic group followed by Tukey's test used to estabilish mean values within the same group. The significance level of all tests was set at 5%.
RESULTS

Control
Group's HR did not significantly change among recorded times, while within the tramadol group (TG) the heart rate decreased. The respiratory frequency average within the control group was significantly higher than the observed into the tramadol group, especially from T30 until the end of the experiment. No important variation in body temperature (BT) was recorded. Within the three different kinds of blood pressure evaluated, control group's (CG) averages were consistently lower than those recorded into the tramadol group (TG) from T15 until T60. When studying the groups separately, CG did not exhibit differences between times. On the other hand, TG (tramadol group) did show a decrease in the measured pressure values from T15 to T60. The analysis of the TG SpO 2 showed significant difference at T30. Results obtained for PETCO 2 did not show differences between the groups. When analyzed within the groups, GT showed higher PETCO 2 averages from T30 to T60 (Table 1) .
The blood gas analyses showed no significant reduction of the pH baseline values with the administration of tramadol and were stable throughout the experiment.
The PaO 2 values remained constant within the groups during anesthesia. The PaCO 2 increased in both groups with anesthesia (CG and TG) and remained constant until the end of the experimental period. Statistical difference was observed only at T60 which GT mean value of PaCO 2 was lower than T0. SaO 2 remained at 100% for both groups throughout the anesthetic period. BD and HCO 3 did not change significantly during anesthesia within groups and between groups (Table 2). 
DISCUSSION
Since the objective of this study was to evaluate blood gas and cardiorespiratory changes elicited by tramadol during sevoflurane anesthesia, it was decided the laboratorial and clinical parameters assessed should be those most commonly practiced routinely.
Sevoflurane did not alter HR, on the other hand, within the treated group, tramadol induced a negative chronotropic effect, reducing the HR 15 minutes after its administration, remaining unchanged until the end of experiment (MILDH, 2007) . Such event is related to the increase in vagal activity elicited by tramadol (BOVILL, SEBEL, STANLEY, 1984) although this effect is more evident when tramadol is administered intravenously compared to intramuscularly used in this study. Tramadol reduced the HR significantly of TG, from T15 when compared to the CG and also from TG when compared to T0, in other words, administration of tramadol will reduce the HR (T15-T60).
The RR behaved differently between CG and TG and presented significant differences between them, demonstrating reduction in RR from moment 30 (after tramadol injection) and remaining lower throughout the rest of the experiment. The association may produce a more severe respiratory depression, once opioids are respiratory system depressants (BOVILL, SEBEL, STANLEY, 1984) .
Most anesthetics promote a progressive and gradual reduction in body temperature. This takes place due to several factors such as basal metabolism decrease, arterial pressure lowering, peripheral vasodilation and body surface area (NUNES, 1995) . Since there was no significative difference between groups throughout the experiment, it becomes evident that the temperature reduction did not influence negatively the other observed variables.
The arterial blood pressure decreased within the group control, which could be attributed to a decrease in the systemic vascular resistance (SVR) caused by the volatile anesthetics (NAVARRO et al., 1994; CLARKE et al., 1996; SANTOS et al., 2013) . However, the use of tramadol in TG caused a decrease in the systolic, diastolic and mean arterial blood pressures due to the depressant action of tramadol (MONTEIRO et al., 2009) .
There has been a significant difference in blood pressure within the TG at moment 15, which coincided with the reduction of the HR, thus reducing tissue perfusion (WHITE et al., 1990) .
The increase in PETCO 2 , along with the inevitable PaCO 2 increase, stimulates chemosensitive areas within the medulla oblongata, thus stimulating breathing, allowing more CO 2 to be eliminated through the lungs. However, if there should be a respiratory depression this process may be hindered (ÉVORA et al., 1999) . The fact that tramadol produced significant increase in PaCO 2 688 Cardiopulmonary and acid-base… LACERDA, M. S. et al.
only 60 minutes after its administration is justifiable once events that influence the respiratory dynamics do not produce immediate responses, thus, sometime is necessary for the decrease in RR to influence blood PaCO 2 for it can be detectable by blood gas (CLARKE et al., 1996) . PaO 2 , HCO 3 , DB e pH values did not vary significantly neither within different moments nor between both groups.
CONCLUSION
The results allow us to conclude that tramadol in cats anesthetized with sevoflurane does not cause significant cardiorespiratory and blood gas changes. Although there are significant differences in some parameters between groups, all results remained within feline physiological averages.
